Annapolis Financial Services’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10
Closed -$2K 551
2022
Q3
$2K Hold
10
﹤0.01% 466
2022
Q2
$2K Hold
10
﹤0.01% 400
2022
Q1
$3K Hold
10
﹤0.01% 396
2021
Q4
$4K Hold
10
﹤0.01% 382
2021
Q3
$3K Hold
10
﹤0.01% 386
2021
Q2
$3K Hold
10
﹤0.01% 367
2021
Q1
$3K Hold
10
﹤0.01% 351
2020
Q4
$3K Buy
+10
New +$2.77K ﹤0.01% 355

Other funds holding ABMD

Annapolis Financial Services's ABMD Position: Q4 2022 in Review

Annapolis Financial Services sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 10 shares — an estimated $2K sold.

Annapolis Financial Services first reported a position in ABMD in Q4 2020 and held it in 8 quarters. The position peaked at $4K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Annapolis Financial Services reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Annapolis Financial Services sold 10 Abiomed Inc shares in Q4 2022, an estimated $2K.
  • Annapolis Financial Services first reported a position in Abiomed Inc in Q4 2020 and held it in 8 quarters.
  • Annapolis Financial Services's Abiomed Inc position peaked at $4K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Annapolis Financial Services's 13F filing for Q4 2022, filed 23 Jan 2023.